These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1503446)

  • 21. Effect of oral administration of calcium carbonate, aluminum hydroxide gel and dihydrotachysterol on renal acidosis.
    Ueda H; Ikeda H; Sasaki Y; Shioji R
    Tohoku J Exp Med; 1978 Jan; 124(1):1-11. PubMed ID: 635890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on the interactions during storage of compounds of the antacid group. I. Interactions of the components in suspensions].
    Pawlaczyk J; Lutka A
    Acta Pol Pharm; 1989; 46(1):74-80. PubMed ID: 2816464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of antacids on the absorption of simultaneously ingested iron.
    O'Neil-Cutting MA; Crosby WH
    JAMA; 1986 Mar; 255(11):1468-70. PubMed ID: 3005669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers.
    Krishna G; Kisicki JC; Olsen S; Grasela DM; Wang Z
    Pharmacotherapy; 2007 Jul; 27(7):963-9. PubMed ID: 17594201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of multiple staggered doses of calcium on the bioavailability of ciprofloxacin.
    Lomaestro BM; Bailie GR
    Ann Pharmacother; 1993 Nov; 27(11):1325-8. PubMed ID: 8286801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of ferrous ions, calcium ions and citric acid on absorption of ciprofloxacin across caco-2 cells: practical and structural approach.
    El-Sabawi D; Abu-Dahab R; Zalloum WA; Ijbara F; Hamdan II
    Drug Dev Ind Pharm; 2019 Feb; 45(2):292-303. PubMed ID: 30348012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of norfloxacin absorption by antacids.
    Nix DE; Wilton JH; Ronald B; Distlerath L; Williams VC; Norman A
    Antimicrob Agents Chemother; 1990 Mar; 34(3):432-5. PubMed ID: 2334155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of an antacid containing magnesium and aluminum on absorption, metabolism, and mechanism of renal elimination of pefloxacin in humans.
    Jaehde U; Sörgel F; Stephan U; Schunack W
    Antimicrob Agents Chemother; 1994 May; 38(5):1129-33. PubMed ID: 8067750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of antacids on the bioavailability of diflunisal in the fasting and postprandial states.
    Tobert JA; DeSchepper P; Tjandramaga TB; Mullie A; Buntinx AP; Meisinger MA; Huber PB; Hall TL; Yeh KC
    Clin Pharmacol Ther; 1981 Sep; 30(3):385-9. PubMed ID: 7023791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multiple-dose pharmacokinetic interaction study between didanosine (Videx) and ciprofloxacin (Cipro) in male subjects seropositive for HIV but asymptomatic.
    Knupp CA; Barbhaiya RH
    Biopharm Drug Dispos; 1997 Jan; 18(1):65-77. PubMed ID: 9008270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium carbonate as a phosphate binder in dialysis patients: evaluation of an enteric-coated preparation and effect of additional aluminium hydroxide on hyperaluminaemia.
    Ittel TH; Schäfer C; Schmitt H; Gladziwa U; Sieberth HG
    Klin Wochenschr; 1991 Jan; 69(2):59-67. PubMed ID: 2027271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antacid therapy--changes in mineral metabolism.
    Herzog P; Holtermüller KH
    Scand J Gastroenterol Suppl; 1982; 75():56-62. PubMed ID: 6293043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Determination of neutralization capacity of antacids in gastric juice].
    Halter F
    Z Gastroenterol; 1983 Mar; 21 Suppl():33-40. PubMed ID: 6858409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended neutralization of gastric contents with Ducon.
    Riegel N; Tesler MA; Zimmon DS; Jolly ER
    Am J Dig Dis; 1974 Apr; 19(4):335-7. PubMed ID: 4595261
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical study on the influence of a fixed-dose combination of famotidine with calcium carbonate and magnesium hydroxide on the bioavailability of famotidine.
    Zhai Q; Fu J; Huang X; Xu B; Yuan YZ; Jiang T; Rong ZX; Chen HZ
    Arzneimittelforschung; 2008; 58(11):581-4. PubMed ID: 19137909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Determination of formulation quantities for three kinds of antacid using triangle coordinates].
    Sofue M; Ueda Y; Yamamoto M; Yamasaki T; Manabe T
    Yakugaku Zasshi; 1997 Mar; 117(3):185-92. PubMed ID: 9109346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of aluminum hydroxide and famotidine on bioavailability of tosufloxacin in healthy volunteers.
    Minami R; Nakamura C; Inotsume N; Nakano M
    Antimicrob Agents Chemother; 1998 Feb; 42(2):453-5. PubMed ID: 9527806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiotelemetric comparison of two antacids using the Heidelberg capsule.
    Gómez Puch LM; Ríos Solans G; Muñoz y Fernandez JR
    Arzneimittelforschung; 1984; 34(10A):1378-80. PubMed ID: 6548925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.
    Grunder G; Zysset-Aschmann Y; Vollenweider F; Maier T; Krähenbühl S; Drewe J
    Antimicrob Agents Chemother; 2006 Jan; 50(1):68-72. PubMed ID: 16377669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.